| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Meropenem | Meropenem EP Impurity A | VE009469 | View CAS 1053703-36-8 |
| Meropenem | Meropenem EP impurity B | VE009471 | View CAS 166901-45-7 |
Meropenem Impurities
| Parent Drug Name | Name of Impurity | Catalogue No. | |
|---|---|---|---|
| Meropenem | Meropenem EP Impurity A | VE009469 | View CAS 1053703-36-8 |
| Meropenem | Meropenem EP impurity B | VE009471 | View CAS 166901-45-7 |
| Catalogue No. | VE009469 |
| CAS No. | 1053703-36-8 |
| Molecular Formula | C17H27N3O6S |
| Molecular Weight | 401.5 g/mol |
| Parent drug | Meropenem |
| IUPAC Name | (4R, 5S)-5-[(1S, 2R)-1-carboxy-2-hydroxypropyl]-3-[[(3S, 5S)-5-[(dimethylamino)carbonyl]pyrrolidin-3-yl]sulfanyl]-4-methyl-4, 5-dihydro-1H-pyrrole-2-carboxylic acid |
| Synonyms | Meropenem Open-Ring Impurity |
| References | Sci-Hub, Meropenem. Drugs, 59(3), 653–680, 10.2165/00003495-200059030-00016. (2022). Retrieved June 12, 2022, from Sci-hub.se website: https://sci-hub.se/https://doi.org/10.2165/00003495-200059030-00016 |
| Status | In-stock |
| ListName | Meropenem EP Impurity A |
| Exclusively Supplied by Veeprho | Exclusively Supplied by Veeprho |
"*" indicates required fields
